Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Immunology
Study Phase : Phase III
Sponsor : BioClever 2005 | NTS Hub S.L.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 02, 2022
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Immunology
Highest Development Status : Phase III
Sponsor : BioClever 2005 | NTS Hub S.L.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase III
Sponsor : BioClever 2005 | NTS Hub S.L.
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 06, 2021
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase III
Sponsor : BioClever 2005 | NTS Hub S.L.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 29, 2016
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 25, 2016
Lead Product(s) : Dermatophagoides Pteronyssinus
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable